Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Amsterdam  >  Esperite N.V.    ESP   NL0009272137

Delayed Quote. Delayed  - 09/23 05:29:01 pm
1.278 EUR   -0.54%
08/29 ESPERITE N : ESP) announces additional information on envisaged fina..
08/29 ESPERITE N : .V. (ESP) announces additional information on envisaged..
08/23 ESPERITE N : .V. (ESP) publishes revenue increase of 6% compared to ..
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsSector news 

CRYO SAVE GROUP : -Save Group N.V.: Purchase Shares Chairman

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/03/2011 | 07:05am CEST

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 16,700 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price of ?4.14 on 1 November 2011.

Following this purchase, Mr Johan Goossens is beneficially interested in 1,316,703 ordinary shares, representing approximately 14.1% of the Group's issued share capital.

Enquiries:

Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181
Kees Jongsma/Leon Melens

Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Sean Lunn
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield

Free footage is available on www.videobankonline.com:
http://www.videobankonline.com/

About Cryo-Save (www.cryo-save.com/group:
http://www.cryo-save.com/group)

Cryo-Save, the leading international family stem cell bank, already stores more than 194,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be cured by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).

Click here for PDF press release:
http://hugin.info/143308/R/1560195/482625.pdf



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE

HUG#1560195
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ESPERITE N.V.
08/29 ESPERITE N : ESP) announces additional information on envisaged financing
08/29 ESPERITE N : .V. (ESP) announces additional information on envisaged financing
08/23 ESPERITE N : .V. (ESP) publishes revenue increase of 6% compared to HY1 2015 and..
06/15 ESPERITE N.V. : important recurrent financial improvements from Laboratory trans..
05/31 ESPERITE N V : .V. is confident in its future and successes
05/31 ESPERITE N V : .V. is confident in its future and successes
04/29 ESPERITE N.V. : Trading update Q1-2016
04/28 ESPERITE N V : (ESP) financial results for 2015 published
04/28 ESPERITE N V : (ESP) convenes Annual General Meeting of Shareholders
04/22 ESPERITE N V : DAVID and GOLIATH – Genoma sued by Illumina. Notice of Pate..
More news
Sector news : Healthcare Facilities & Services - NEC
09/16 FTSE falls as banking stocks lose ground
09/14DJBusiness Watch -- WSJ
09/13DJUNITEDHEALTH : Optum Unit to Oversee Quest Diagnostics' Billing Processes
09/13DJUNITEDHEALTH : Optum Unit to Oversee Quest Diagnostic's Billing Processes
09/05DJFRESENIUS : to Buy Spanish Hospital Group Quironsalud for 5.76 Billion Euros
More sector news : Healthcare Facilities & Services - NEC
Advertisement
Chart ESPERITE N.V.
Duration : Period :
Esperite N.V. Technical Analysis Chart | ESP | NL0009272137 | 4-Traders
Full-screen chart
Technical analysis trends ESPERITE N.V.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Managers
NameTitle
Frédéric Amar Chief Executive Officer & Executive Director
Fabrizio Favara Chief Operating Officer
Gilbert Verhoef Finance Manager
Samuel Amar Head-Information Technology Department
Marcin Jurga Manager-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ESPERITE N.V.-45.62%0
HCA HOLDINGS INC12.55%28 823
FRESENIUS MEDICAL CARE..3.60%28 112
LABORATORY CORP. OF AM..11.12%14 055
DAVITA INC-4.60%13 759
UNIVERSAL HEALTH SERVI..2.88%11 975
More Results